110 related articles for article (PubMed ID: 16168193)
1. Genotyping cytochrome P450 3A5 using the Light Cycler.
Fredericks S; Moreton M; MacPhee IA; Mohamed M; Marlowe S; Jorga A; Johnston A; Carter ND; Holt DW
Ann Clin Biochem; 2005 Sep; 42(Pt 5):376-81. PubMed ID: 16168193
[TBL] [Abstract][Full Text] [Related]
2. Multiplex PCR-pyrosequencing assay for genotyping CYP3A5 polymorphisms.
Aquilante CL; Langaee TY; Anderson PL; Zineh I; Fletcher CV
Clin Chim Acta; 2006 Oct; 372(1-2):195-8. PubMed ID: 16701601
[TBL] [Abstract][Full Text] [Related]
3. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.
Thervet E; Anglicheau D; King B; Schlageter MH; Cassinat B; Beaune P; Legendre C; Daly AK
Transplantation; 2003 Oct; 76(8):1233-5. PubMed ID: 14578760
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.
Suh JW; Koo BK; Zhang SY; Park KW; Cho JY; Jang IJ; Lee DS; Sohn DW; Lee MM; Kim HS
CMAJ; 2006 Jun; 174(12):1715-22. PubMed ID: 16754899
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus.
Zhao Y; Song M; Guan D; Bi S; Meng J; Li Q; Wang W
Transplant Proc; 2005; 37(1):178-81. PubMed ID: 15808586
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients.
Larriba J; Imperiali N; Groppa R; Giordani C; Algranatti S; Redal MA
Transplant Proc; 2010; 42(1):257-9. PubMed ID: 20172323
[TBL] [Abstract][Full Text] [Related]
7. CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.
Zhenhua L; Tsuchiya N; Narita S; Inoue T; Horikawa Y; Kakinuma H; Kato T; Ogawa O; Habuchi T
Cancer Lett; 2005 Jul; 225(2):237-43. PubMed ID: 15876487
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of cytochrome P450 3A5 in Chinese.
Chou FC; Tzeng SJ; Huang JD
Drug Metab Dispos; 2001 Sep; 29(9):1205-9. PubMed ID: 11502729
[TBL] [Abstract][Full Text] [Related]
9. Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects.
Kim KA; Park PW; Lee OJ; Kang DK; Park JY
J Clin Pharmacol; 2007 Jan; 47(1):87-93. PubMed ID: 17192506
[TBL] [Abstract][Full Text] [Related]
10. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism analysis of CYP3A5 in myeloid leukemia.
Liu TC; Lin SF; Chen TP; Chang JG
Oncol Rep; 2002; 9(2):327-9. PubMed ID: 11836601
[TBL] [Abstract][Full Text] [Related]
12. CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy.
Wong M; Balleine RL; Collins M; Liddle C; Clarke CL; Gurney H
Clin Pharmacol Ther; 2004 Jun; 75(6):529-38. PubMed ID: 15179407
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients.
Wei-lin W; Jing J; Shu-sen Z; Li-hua W; Ting-bo L; Song-feng Y; Sheng Y
Liver Transpl; 2006 May; 12(5):775-80. PubMed ID: 16628701
[TBL] [Abstract][Full Text] [Related]
14. Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French population.
Quaranta S; Chevalier D; Bourgarel-Rey V; Allorge D; Solas C; Lo-Guidice JM; Sampol-Manos E; Vacher-Coponat H; Moal V; Broly F; Lhermitte M; Lacarelle B
Toxicol Lett; 2006 Jul; 164(2):177-84. PubMed ID: 16442753
[TBL] [Abstract][Full Text] [Related]
15. [Expression of CYP3A5 mRNA in children with acute leukemia].
Huang Z; Chai YH; Cen JN; He HL; Li J
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):549-54. PubMed ID: 19650988
[TBL] [Abstract][Full Text] [Related]
16. No association of the CYP3A5*1 allele with blood pressure and left ventricular mass and geometry: the KORA/MONICA Augsburg echocardiographic substudy.
Lieb W; Bolbrinker J; Döring A; Hense HW; Erdmann J; Schunkert H; Kreutz R
Clin Sci (Lond); 2006 Dec; 111(6):365-72. PubMed ID: 16822233
[TBL] [Abstract][Full Text] [Related]
17. Effect of cytochrome P450 3A5*3 genotype on the stereoselective pharmacokinetics of amlodipine in healthy subjects.
Kim KA; Park PW; Park JY
Chirality; 2009 May; 21(5):485-91. PubMed ID: 18752284
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjects.
Jin Y; Wang YH; Miao J; Li L; Kovacs RJ; Marunde R; Hamman MA; Philips S; Hilligoss J; Hall SD
Clin Pharmacol Ther; 2007 Nov; 82(5):579-85. PubMed ID: 17443134
[TBL] [Abstract][Full Text] [Related]
19. Application of real-time PCR and melting curve analysis in rapid detection of Ael and Bel blood types.
Chen DP; Tseng CP; Lin HT; Sun CF
Ann Clin Lab Sci; 2005; 35(1):25-30. PubMed ID: 15830706
[TBL] [Abstract][Full Text] [Related]
20. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
Kuehl P; Zhang J; Lin Y; Lamba J; Assem M; Schuetz J; Watkins PB; Daly A; Wrighton SA; Hall SD; Maurel P; Relling M; Brimer C; Yasuda K; Venkataramanan R; Strom S; Thummel K; Boguski MS; Schuetz E
Nat Genet; 2001 Apr; 27(4):383-91. PubMed ID: 11279519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
